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Dr Robert Rutherford (Corpus Christi, Tex). My question
has to do with your stated primary end point of aneurysm-related
death. It is a long-term end point, not a perioperative end point.
Although it is a soft end point whose accuracy depends on whether
the death was really witnessed or an autopsy was done and tends to
perpetuate any perioperative advantage that EVAR [endovascular
aneurysm repair] might have, my point is that you are really
comparing postoperative mortality from this NIS [Nationwide
Inpatient Sample] data, aren’t you?
Dr Kristina Giles. The NIS is an administrative database that
is primarily based upon hospital discharge information. The pa-
tients that we are able to capture in the NIS are patients that
present to a hospital and then are diagnosed with either an intact
AAA [abdominal aortic aneurysm] or a ruptured AAA. Further in
our study, intact patients were included if they went on to have a
repair, whereas ruptured AAA patients we measured whether or
not they went on to repair. We do not have autopsy information
and make the assumption that there should not be a significant
change in the number of patients that die of aneurysm rupture
before making it to a hospital.
DrRutherford. So you are really presenting just perioperative
mortalities?
Dr Giles. Yes.
Dr JonMatsumura (Chicago, Ill). Aneurysm-related mortal-
ity normally includes the periprocedural (inpatient and within 30
days) deaths after initial treatment and reintervention and from
rupture. Since your group has done great work looking at these
reinterventions after endo and open repairs, were you also count-
ing aneurysm-related mortality after these secondary interventions
in this study?
Dr Giles. This is inpatient only database; therefore, we don’t
have follow-up data with this particular study. We are unable to
look at deaths related to secondary interventions, unless they were
still in the hospital at the time.
Dr Anton Sidawy (Washington, DC). Any addition, Dr
Schermerhorn?
DrMarc Schermerhorn.Wewill have that for you in the near
future with the deaths related to reinterventions, but using a
different database.
Dr Sidawy. Am I correct that the total number of aneurysms
repaired over time has remained constant?
Dr Giles. It has remained relatively stable when you ac-
count for both intact and ruptured aneurysms. The mean annual
volume has increased by approximately one thousand from a
pre-endovascular to postendovascular time point.
Dr Sidawy. That indicates that the appropriate operation
continues to be performed for the appropriate indication and that
surgeons have not changed or relaxed their indication for AAA
repair just because EVAR is somewhat simpler and less time
consuming. Also, some of us think that since after EVAR the
aneurysms done with open repair are the more difficult ones;
therefore, the results of open repair may be getting worse. How-
ever, I gather that your results have not confirmed this assumption,
in the number of AAA-related deaths encompassing patients un-since mortality rate even for open repair has gone down over the
years.
Dr Giles. Correct, even for open the mortality has decreased
slightly. When you look at a pre-endovascular to postendovascular
period, the mortality rate was 4.7% vs 4.5%. So open repair mor-
tality is certainly not going up.
Dr Schermerhorn. And I’ll just back up your comment, Dr
Sidawy. We were concerned because when laparoscopic cholecys-
tectomy came out, the procedure volume went up so much that
despite the lower operative mortality there was no decrease in
cholecystectomy-related death. So we were worried that perhaps
we are expanding AAA repair to patients who are so old they are
going to die before rupture or their AAA is so small they don’t need
a repair, but that does not seem to be the case. So we are happy to
see these results.
Dr Wilhelm Sandmann (Düsseldorf, Germany). As I under-
stand the message of your paper, it is to use more endovascular
treatment and you will have lower mortality rates. I don’t think
that your paper can prove this because, since endovascular treat-
ment arrived on the market, there are a lot more small aneurysms
being repaired, which probably have lesser mortality with either
open repair or EVAR. So my suspicion is that the number, which
increased in the second period, has to do with better patients and
better outcome. Do you know if those aneurysms which are
appearing in the second period have the same morbidity and
mortality criteria as in the first period?
Dr Giles. We don’t have any anatomic data from this data-
base, so I can’t tell you if they are smaller or not. However, we do
know from prior studies that an EVAR cohort typically has a
greater number of comorbidities and is older than an open repair
cohort. In this study, the age for all repairs is increasing over time.
The average age in the postendovascular era, with the aging
population, has actually increased by about 2 years. So just extrap-
olating from that, you would assume that some of these patients
are more ill after EVAR became an option. So I would not
conclude that it is a healthier population that is being operated on
based on that.
Dr Krish Soundararajan (Philadelphia, Pa). I believe that
NIS data that you have chosen for your study categorizes the
hospitals based on the region and case volume. There are several
reports that in general suggest better outcome of vascular inter-
ventions in the high-volume centers. Were you able to see any such
difference based on the regions or volume in your analysis?
DrGiles.We did not look at regional variations for this study;
however, that is something that could be done in future work. NIS
data have been used in the past to show a volume–outcome
relationship, with higher volume associated with lower mortality
rates for both open repair and EVAR for intact aneurysms. We did
not repeat this in the current study. We did however analyze the
hospital volume–outcome relationship for ruptured aneurysms in a
separate study that will be presented also at this meeting. This
showed that there was a mortality benefit for higher-volume cen-
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Dr Schermerhorn and colleagues have documented the
changes in procedural volume and in-hospital mortality for ab-
dominal aortic aneurysm (AAA) repair in the United States after
the introduction of endovascular aneurysm repair (EVAR) using
the National Inpatient Sample. They reported that the introduc-
tion of EVAR was associated with approximately a 40% reductiondergoing repair of intact aneurysms, ruptured aneurysms, and
those with ruptured aneurysms that were not repaired. Somewhat
surprisingly, the total number of repairs performed annually (both
open and EVAR) has not increased significantly, but there has been
an increase in the number of intact repairs and a corresponding
decrease in ruptured repairs. The authors have documented that
most intact AAA repairs are currently performed using the endo-
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is largely responsible for the decreases in procedural-related mor-
tality even though the average patient age is significantly greater in
the post-EVAR era.
The reported results are very encouraging, and we should all
take some measure of pride in the fact that the aneurysm-related
mortality rate appears to be decreasing. However, the results need
to be interpreted with some caution given the limitations of the
study and the administrative database.
First, it is important to remember that the primary outcome
measure is in-hospital, procedural-related mortality. Similar to the
early results of the Dutch Randomised Endovascular Aneurysm
Management (DREAM)1 and EVAR-12 trials, the observed ben-
efits in procedural-related mortality may not actually translate into
a longer-term survival benefit.
Second, the true effect on the population as a whole in terms
of aneurysm-related mortality remains unknown because it is likely
that a significant number of patients die with ruptured aneurysms
outside of the hospital setting and, therefore, would not be ac-
counted for in the current report.
Third, the study is a retrospective analysis that uses an admin-
istrative database of nonfederal hospitals. Despite their utility,
these administrative databases are not designed specifically to
answer clinical questions and are fraught with problems in terms of
the accuracy and reliability of the data. Indeed, it was somewhat
surprising that the survival rate for nonrepaired, ruptured aneu-
rysms was 30%.
Fourth, the indications for the procedures are not available.
Although unlikely, it is conceivable that the post-EVAR reduction
in mortality resulted from a more widespread application of thetechnique to better-risk patients or those with smaller aneurysms
(eg,5 cm), or both. It has clearly been our anecdotal impression
that the patients undergoing open repair in the post-EVAR era are
more complicated both in terms of comorbidities and anatomy.
Ideally, these exciting results should serve as stimuli to further
clarify the observations and continue to improve the overall care
for patients with AAAs. The latter objective is contingent upon the
identification of the presence of an aneurysm, refining the indica-
tions for repair, and improving the perioperative and longer-term
outcomes. The Screening Abdominal Aortic Aneurysm Very Effi-
ciently Act (SAAAVE) established a screening protocol for Medi-
care beneficiaries, but the indications are narrower than those
recommended by the position statement of the Society for Vascu-
lar Surgery and its impact remains uncertain. The national and
international randomized trials comparing open repair vs expectant
management and open repair vs EVAR have begun to define the
appropriate treatment paradigms. However, it is contingent upon
us to incorporate the evidence from these trials in to our own
practices.
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